Sign in
CompletedNo phase

PF-Organized Corticosteroid-Associated Heterogeneity in Sepsis

Key facts

Who runs it
Shanghai Zhongshan Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
2,693 people enrolled
Started
5 Aug 2026
Ended
27 Sept 2026
Type of study
Observational, 3 groups
Treatments tested
  • Systemic Corticosteroids
Record updated
3 November 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • ICU stays or eligible ICU records from the ICCA, MIMIC, or eICU databases
  • Meets the database-specific operational definition of sepsis used in the study
  • Has an ascertainable ICU mortality outcome or the corresponding harmonized database-specific mortality endpoint
  • Has the relevant corticosteroid exposure and clinical data required for the corresponding analysis

Who cannot take part

  • For the ICCA cohort, records with antimicrobial treatment patterns more consistent with postoperative prophylaxis than active infection
  • ICU stays or records that do not meet the finalized database-specific sepsis definition
  • For the ICCA cohort, ICU stays with a duration of 48 hours or less
  • Records with unavailable or invalid mortality outcome information
  • Records with missing exposure or other essential variables required for the corresponding analysis; Analysis-specific exclusions:
  • Records without available PaO₂/FiO₂ measurements were excluded from analyses requiring P/F stratification, but were not necessarily excluded from the broader source cohort
  • Records with missing model-specific covariates were excluded from the corresponding complete-case analyses only

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This retrospective multicohort observational study evaluates whether the PaO2/FiO2 ratio (P/F ratio) organizes heterogeneity in the association between early systemic corticosteroid exposure and mortality among critically ill patients with sepsis.

Read full original descriptionShow less

The study uses one internal critical-care cohort (ICCA) and two external critical-care databases (MIMIC and eICU). Analyses include internal discovery, broad external testing, reconstruction of external cohorts toward vasopressor-anchored shock-decision contexts, realized-exposure observational analyses, and strategy-level analyses using a simplified clone-censor-weighting framework (Lite-CCW).

The primary objective is to characterize whether corticosteroid-associated outcome patterns differ across P/F strata and whether similar directional patterns are observed across independent ICU datasets after decision-context reconstruction. The study is hypothesis-generating and does not assign corticosteroid treatment or define a clinical treatment-selection rule.

The 3 groups in the trial

  • ICCA Cohort

    Critically ill patients meeting the finalized ICCA sepsis phenotype. Realized systemic corticosteroid exposure was assessed within 0-72 hours after cohort time zero. The finalized manuscript-facing ICCA cohort included 2,693 ICU stays.

    Treatment: Systemic Corticosteroids

  • MIMIC Cohort

    Patients represented in the broad MIMIC ICU cohort, with reconstructed main and shock-aligned subsets used for external decision-context analyses. Realized corticosteroid exposure was assessed within 0-24 hours after time zero.

    Treatment: Systemic Corticosteroids

  • eICU Cohort

    Patients represented in the broad eICU critical-care cohort, with reconstructed main and shock-aligned subsets used for external decision-context analyses. Realized corticosteroid exposure was assessed within 0-24 hours after time zero.

    Treatment: Systemic Corticosteroids

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Decision-Context-Aligned Multicohort Framework for PF-Organized Corticosteroid-Associated Heterogeneity in Sepsis
Record updated
3 November 2026